Peripheral Vascular Devices Market

The Peripheral Vascular devices market is projected to reach USD  14.73 billion by 2029 from USD 11.43  billion in 2024, at a CAGR of 5.2 % from 2024  to 2029. The growth in the peripheral vascular devices market is seen due to an increase in the geriatric population, habits such as smoking and sedentary lifestyles are increasing the diabetic population and obesity in individuals leading to the increase in the Peripheral vascular devices for screening and further surgeries.

The Peripheral Vascular devices market is fragmented. A few strong players in this market are Boston Scientific Corporation (U.S.), Medtronic ( U.S), Philips(Japan), Merit Medical Systems (U.S.), Abbott (U.S.), and Terumo Corporation (Japan) among others.

To know about the assumptions considered for the study download the pdf brochure

BOSTON SCIENTIFIC CORPRATION (U.S)

Boston Scientific Corporation is the world's leader in developing, manufacturing, and marketing medical devices for a variety of health sciences. Those include peripheral vascular interventions and interventional cardiology, along with endoscopy and many others. Under the peripheral vascular devices section, the company provides a wide portfolio of pioneering products that are designed to treat diseases of the vascular system. These include drug-eluting stents, atherectomy systems, embolic protection devices, guidewires, catheters, and balloon dilation devices. Peripheral vascular applications of their well-known products include Eluvia Drug-Eluting Vascular Stent System, ROTAPRO Rotational Atherectomy System, AngioJet Thrombectomy System, and Mustang PTA Balloon Catheter. It applies to these complex cases diagnosed for PAD, CLI, and several vascular diseases involving arteries and veins except for the heart and brain.

Boston Scientific continues to build its portfolio through acquisitions that strengthen its presence in vascular devices. Peripheral vascular has among its subsidiaries key contributors, like BTG International-an interventional medicine company focused on vascular diseases and cancer-and Claret Medical with its embolic protection device Sentinel Cerebral Protection System. It should also be noted that Baylis Medical, specialized in advanced cardiology and vascular instruments, was acquired by Boston Scientific Corporation to further build up its interventional suite. Acquisitions give Boston Scientific the ability to provide comprehensive solutions by aiding physicians in the treatment of the entire continuum of vascular conditions.

Terumo Corporation (Japan)

Terumo Corporation is a Tokyo, Japan-based company, especially named for its excellence in the concepts of cardiovascular and vascular care. Peripheral vascular devices, as part of their extensive offerings, emphasize the treatment of PAD (peripheral artery disease), DVT (deep vein thrombosis), and other arterial and venous conditions outside the heart and brain. Products include minimally invasive technologies to advanced therapeutic systems, aiding physicians in efforts to improve patient outcomes while minimizing complications of vascular diseases. Some of the products offered by Terumo Corporation in the peripheral vascular devTerumo's subsidiaries have complemented the company's strong push in the global peripheral vascular market. Of the most important of these, Terumo Interventional Systems (TIS) is actively developing technologies for vascular access, embolization, and peripheral vascular interventions. MicroVention, Inc., another Terumo subsidiary, is primarily engaged in neurovascular interventions, though they have products complementary to Terumo's vascular portfolio, especially in embolization and microcatheter technologies. In addition, Terumo Medical Corporation is responsible for the development and distribution of Terumo's interventional products in key markets and supports the further growth of the company's business in the global peripheral vascular market.ices market are Peripheral stents, Drug-eluting stents, and guidwires among others.

Medtronic (U.S)

Medtronic is one of the world’s largest medical technology companies, renowned for its innovative medical devices and therapies across various healthcare sectors, including cardiovascular, neurosurgery, diabetes, and vascular interventions. In the peripheral vascular devices market, Medtronic plays a pivotal role by offering a wide range of products designed to treat peripheral artery disease (PAD), deep vein thrombosis (DVT), and other conditions affecting the peripheral vasculature. Medtronic’s cutting-edge devices assist healthcare professionals in restoring blood flow and improving patient outcomes in cases involving narrowed or blocked arteries outside the heart and brain. The company offers IN.PACT Admiral drug-coated balloon, vascular stents, Atherectomy systems, and Endovascular aneurysm repair stents among others.

Medtronic’s leadership in the peripheral vascular market is further enhanced by its subsidiaries and strategic acquisitions. Covidien, a major acquisition, has significantly bolstered Medtronic's portfolio in the vascular space. Covidien brought products such as ClosureFast and Venaseal, which are used for treating chronic venous insufficiency. Additionally, Aptus Endosystems, which specializes in endovascular aneurysm repair technologies, complements Medtronic’s offerings with its Heli-FX EndoAnchor System. Another critical acquisition is Ardian, which focuses on renal denervation, contributing to Medtronic's advanced therapeutic solutions for vascular conditions

Related Reports:

Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Hemodynamic flow alteration devices), Region - Forecast to 2029

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]